Hmmm...top line is the mover information: Great
Post# of 72440
(Total Views: 258)
Posted On: 10/31/2017 10:53:23 PM
Hmmm...top line is the mover information:
Great efficacy with endoscope images.
No SAEs.
Low systemic exposure numbers (far, far lower than B-ABSSSI).
Not sure what else the market would be looking at. All that stuff was highlighted in the presentations. Maybe a little more in depth PK data? The next big B-UP update I am expecting is either a partnership or a formulation update. B-OM will likely be where we go for the quick kill with a BTD or shoe-in phase 3.
Great efficacy with endoscope images.
No SAEs.
Low systemic exposure numbers (far, far lower than B-ABSSSI).
Not sure what else the market would be looking at. All that stuff was highlighted in the presentations. Maybe a little more in depth PK data? The next big B-UP update I am expecting is either a partnership or a formulation update. B-OM will likely be where we go for the quick kill with a BTD or shoe-in phase 3.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼